Loading... Please wait... Loading... Please wait...
ESTIMATED
08/10/2021
08/10/2021
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Cumberland Pharmaceuticals Inc. last posted its earnings results on Tuesday, August 10th, 2021. The company reported $-0.07091 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $0.00090999999999999. The company had revenue of 8.50 M for the quarter and had revenue of 39.55 M for the year. Cumberland Pharmaceuticals Inc. has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -2.56. Cumberland Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/10/2024 | Q1 2024 | -$0.14 | $13.01 M | $8.50 M | 03/12/2024 | Q4 2023 | -$0.44 | $24.43 M | $9.35 M | 11/13/2023 | Q3 2023 | -$0.07 | $10.09 M | 08/11/2023 | Q2 2023 | $0.06 | $10.89 M | 05/12/2023 | Q1 2023 | $0.01 | $10.29 M | $9.22 M | 03/13/2023 | Q4 2022 | -$0.17 | $26.13 M | $9.12 M | 11/14/2022 | Q3 2022 | -$0.03 | $11.41 M | 08/12/2022 | Q2 2022 | -$0.09 | $10.30 M | 05/13/2022 | Q1 2022 | -$0.10 | $11.18 M | 03/11/2022 | Q4 2021 | -$0.26 | $12.18 M | $8.32 M | 11/12/2021 | Q3 2021 | -$0.07 | $9.19 M | $8.07 M | 08/13/2021 | Q2 2021 | $0.08 | $8.57 M | $9.06 M | 05/14/2021 | Q1 2021 | $0.01 | $10.54 M | 03/12/2021 | Q4 2020 | -$0.06 | $9.78 M | $10.26 M | 11/13/2020 | Q3 2020 | -$0.03 | $8.61 M | $9.25 M | 08/14/2020 | Q2 2020 | -$0.06 | $9.27 M | $9.60 M | 05/22/2020 | Q1 2020 | -$0.07 | $8.33 M | 03/20/2020 | Q4 2019 | -$0.06 | $11.34 M | $13.68 M | 11/13/2019 | Q3 2019 | -$0.13 | $12.65 M | $10.37 M | 08/14/2019 | Q2 2019 | $0.07 | -$0.04 | -0.11 | $12.59 M | $11.58 M |
|---|
A. Cumberland Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates.
A. The conference call for Cumberland Pharmaceuticals Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Cumberland Pharmaceuticals Inc.'s latest earnings report can be read online.
A. Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) has a recorded annual revenue of $39.55 M.
A. Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) has a recorded net income of $39.55 M. Cumberland Pharmaceuticals Inc. has generated $-0.44 earnings per share over the last four quarters.
A. Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) has a price-to-earnings ratio of -2.56 and price/earnings-to-growth ratio is -0.65.
